Laura Deming

Laura is the founder and managing director of the Longevity Fund, an early stage venture capital fund focused on extending healthy human lifespan. After years working on nematode longevity at the UCSF graduate school, Laura matriculated at MIT at 14 and 2 years later participated in the inaugural Thiel Fellowship class. Since then, she has built Longevity Fund and AGE1, funds focused on helping start and fund longevity companies. Longevity Fund companies have collected >$500M in follow-on funding, resulting in the 2018 IPO of the first company dedicated to reversing the diseases of aging, and multiple programs in clinic to reverse or prevent age-related disease.